Tomalia, et al. 1990 Angew Chem Int Ed Engl 29: 138-175. |
Wu et al., 1994 Bioorgan & Med. Chem Lett vol. 4 No. 3: 449-454. |
Camera et al 1994 J. Nucl Med vol. 35 No. 5: 882-889. |
Roberts et al 1990 Bio Conjugate Chem. vol. 1 No. 5:305-308. |
Better et al Methods Enzym. 1989 vol. 178: 476-496. |
Brown, "Clinical Use Of Monoclonal Antibodies", Co=linical Use Of Monoclonal Antibodies, pp. 227-250 (1991). |
Goldenburg et al., "Targeting, Dosimetry, and Radioimmunotherapy of B-Cell Lymphomas With Iodine-131-Labeled LL2 Monoclonal Antibody", Journal of Clinical Oncology, vol. 9:548-564, (1991). |
Kanellos et al., "Studies Of Methotrexate-Monoclonal Antibody Conjugates For Immunotherapy", Jnci., vol. 75:319-329, (1985). |
Kreitman et al., "Cytotoxicity of Conjugates Between LL.2 And Derivatives Of Pseudomonas Exotoxin Toward B-Cell Non-Hodgkin's Lymphoma", Immunology, vol. 33-344, (1992). |
Kulkarni et al., "Covalent Binding Of Methotrexate To Immunoglobulins And The Effect Of Antibody-Linked Drug On Tumor Growth In Vivo", Cancer Research, vol. 41:2700-2706, (1981). |
Murthy et al., "Lymphoma Imaging With A New Technetium-99m Labelled Antibody, LL2", Nuclear Medicine, pp. 394-401, (1992). |
Orlandi et al., "Cloning Immunoglobulin Variable Domains For Expression By The Polymerase Chain Reaction", Proc. Natl. Acad. Sci. USA, vol. 86:3833-3837, (1989). |
Pawlak-Byczkowska et al., "Two New Monoclonal Antibodies, EPB-1 and EPB-2 Reactive With Human Lymphoma", Cancer, vol. 49:4568-4577, (1989). |
Shih et al., "Site-Specific Linkage Of Methotrexate To Monoclonal Antibodies Using An Intermediate Carrier", Int. J. Cancer, vol. 41:832-839, (1988). |
Shih et al., "A Fluorouridine-Anti-CEA Immunoconjugate Is Therapeutically Effective In A Human Colonic Cancer Xenograft Model", Int. J. Cancer, vol. 46:1101-1106, (1990). |
Shih et al., "Anthracycline Immunoconjugates Prepared By A Site-Specific Linkage Via Amino-Dextran Intermediate Carrier", Cancer Research, vol. 51:4192-4198, (1991). |
Co et al., "Chimeric And Humanized Antibodies With Specificity For The CD33 Antigen", The Journal Of Immunology, vol. 148:1149-1154, (1992). |
Vaughan et al., "Limitations To The Killing Of Tumours Using Radiolabelled Antibodies", The British Journal Of Radiology, vol. 60:567-578, (1987). |
Wallick et al., "Glycosylation Of A V.sub.H Residue Of A Monoclonal Antibody Against .alpha.(1.fwdarw.6) Dextran Increases Its Affinity For Antigen", J. Exp. Med., vol. 168:1099-1109, (1988). |
Wright et al., "Antibody Variable Region Glycosylation: Position Effects On Antigen Binding And Carbohydrate Structure", The EMBO Journal, vol. 10:2717-2723, (1991). |
J.R. Couto et al, Hybridoma, 12, 485-498, 1993. |